Self-harming behavior: Gabapentinoid treatment probably justifies clinical monitoring

Autoaggression under gabapentinoids? Self-harming behavior: Gabapentinoid treatment probably justifies clinical monitoring

An increased risk of self-harm already occurs before the start of gabapentinoid therapy, so a direct pharmacological effect seems unlikely. The reduction in the risk of self-harm cannot be clearly attributed to the use of gabapentinoids.